Show simple item record

dc.contributor.authorSoni, A.
dc.contributor.authorWright, N.
dc.contributor.authorAgwu, J. C.
dc.contributor.authorTimmis, A.
dc.contributor.authorDrew, J.
dc.contributor.authorKershaw, M.
dc.contributor.authorMoudiotis, C.
dc.contributor.authorRegan, F.
dc.contributor.authorWilliams, E. C.
dc.contributor.authorWan, J.
dc.contributor.authorNg, S. M.
dc.date.accessioned2022-04-21T09:39:55Z
dc.date.available2022-04-21T09:39:55Z
dc.date.issued2022-02-01
dc.identifier.citationDiabetes Res Clin Pract. 2022 Feb;184:109196. doi: 10.1016/j.diabres.2022.109196. Epub 2022 Jan 13.
dc.identifier.pmid35033598
dc.identifier.doi10.1016/j.diabres.2022.109196
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/622424
dc.description.abstractReal-time continuous glucose monitoring (rtCGM) and FreeStyle Libre glucose monitoring systems (isCGM) are new evolving technologies used in the management of Type 1 diabetes. They offer potential to improve diabetes control and reduce hypoglycaemia. rtCGM can be linked to insulin pump providing hybrid closed loop therapy. Families of children and young people are keen to have the benefit from these technologies. These are relatively expensive so it is important that health care professionals, families of children and young people (CYP) with diabetes are adequately trained in the use of these devices. Health care professionals need to be able to make patient selection based on individual needs and preferences to achieve maximum benefit. Association of Children's Diabetes Clinicians (ACDC) developed a comprehensive guideline in 2017 to help identify which patients may be most likely to benefit and how these technologies may be practically implemented. Since then new technologies have been introduced and the use of GCM has expanded in routine clinical practice. This article, aims to provide a practical approach and help identify which patients may be most likely to benefit and how the technology may be implemented in order to maximise the clinical benefits.
dc.language.isoeng
dc.publisherElsevier
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0168-8227(22)00008-0
dc.rights© 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/
dc.subjectAdolescent
dc.subjectBlood Glucose
dc.subject*Blood Glucose Self-Monitoring
dc.subjectChild
dc.subject*Diabetes Mellitus, Type 1/drug therapy
dc.subjectHumans
dc.subjectHypoglycemic Agents/therapeutic use
dc.subjectInsulin Infusion Systems
dc.subjectChildren and young people
dc.subjectContinuous Glucose Monitoring
dc.subjectTechnology
dc.subjectTime in range
dc.subjectType 1 diabetes
dc.titleA practical approach to continuous glucose monitoring (rtCGM) and FreeStyle Libre systems (isCGM) in children and young people with Type 1 diabetes
dc.typeJournal Article
dc.identifier.journalDiabetes research and clinical practice
dc.description.noteThe article is available via Open Access. Click on the 'Additional link' above to access the full-text.
dc.type.versionppublish
dc.description.admin-notePublished version, accepted version (12 month embargo), submitted version
dc.date.epub2022-01-17
dc.citation.volume184
dc.citation.spage109196


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

© 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
Except where otherwise noted, this item's license is described as © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.